|
WDR41 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.365100E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.900480E-03 |
| Normal-vs-Stage2 |
2.075800E-02 |
| Normal-vs-Stage3 |
3.545900E-02 |
| Normal-vs-Stage4 |
2.113200E-01 |
| Stage1-vs-Stage2 |
5.861000E-01 |
| Stage1-vs-Stage3 |
5.981800E-01 |
| Stage1-vs-Stage4 |
6.766400E-01 |
| Stage2-vs-Stage3 |
9.675800E-01 |
| Stage2-vs-Stage4 |
4.890000E-01 |
| Stage3-vs-Stage4 |
5.761800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.567300E-04 |
| Normal-vs-AfricanAmerican |
1.620080E-03 |
| Normal-vs-Asian |
1.160750E-01 |
| Caucasian-vs-AfricanAmerican |
6.825400E-01 |
| Caucasian-vs-Asian |
1.102600E-01 |
| AfricanAmerican-vs-Asian |
1.427200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.764370E-03 |
| Normal-vs-Female |
7.70880000000584E-05 |
| Male-vs-Female |
4.096000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.939800E-02 |
| Normal-vs-Extreme_Weight |
6.002600E-03 |
| Normal-vs-Obese |
8.845500E-04 |
| Normal-vs-Extreme_Obese |
2.156800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.770400E-01 |
| Normal_Weight-vs-Obese |
1.981420E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.542800E-01 |
| Extreme_Weight-vs-Obese |
3.553800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.645600E-01 |
| Obese-vs-Extreme_Obese |
7.776400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.196100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.9852399999909E-05 |
| Normal-vs-Age(61-80Yrs) |
7.656600E-03 |
| Normal-vs-Age(81-100Yrs) |
9.122100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.635200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.728400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.148800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.270200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.389000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.963600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.568800E-04 |
| Normal-VS-Type2 PRCC |
3.238400E-03 |
| Normal-VS-KIRP CIMP |
1.461790E-01 |
| Normal-VS-Unclassified PRCC |
1.615350E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.986400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.936400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.556640E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.379600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.693200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.919400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.416390E-01 |
| Normal-vs-N1 |
8.197700E-02 |
| Normal-vs-N2 |
2.557200E-01 |
| N0-vs-N1 |
7.002400E-01 |
| N0-vs-N2 |
7.551800E-01 |
| N1-vs-N2 |
8.968000E-01 |
|
|
